Kevin Mclaughlin - Jun 13, 2023 Form 4 Insider Report for Decibel Therapeutics, Inc. (DBTX)

Role
Director
Signature
/s/ Jeffrey Schulz, Attorney-in-Fact
Stock symbol
DBTX
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/14/2023, 04:37 PM
Previous filing
May 5, 2023
Next filing
Sep 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBTX Common Stock Award $0 +5K $0.00 5K Jun 13, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +5K $0.00 5K Jun 13, 2023 Common Stock 5K $4.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of the Issuer's common stock issuable under 5,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of the Issuer's common stock upon vesting. The RSUs are scheduled to vest in full on the one year anniversary of the date of grant of the RSUs (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the RSUs), subject to the reporting person's continued service.
F2 Includes 5,000 unvested RSUs. Each unvested RSU represents the right to receive one share of the Issuer's common stock upon vesting.
F3 This option was granted on June 13, 2023 for 5,000 shares. The shares underlying the option are scheduled to vest in full on the one year anniversary of the date of grant of the option (or, if earlier, the date of the next annual meeting of stockholders following the date of grant of the option), subject to the reporting person's continued service.

Remarks:

Exhibit Index: 24.1 Power of Attorney